Skip to the content Skip to the Navigation

ClinChoice

  • About ClinChoice
    • Top Message・Corporate Philosophy
    • Company Profile・Our History
    • Leadership Team
    • Group Investors/Group Partners
  • Service Offering
    • Service Sector
      • Regulatory Affairs
      • Clinical Operation
      • Data Management
      • Statistical Analysis/Programming
      • Medical Writting
      • Pharmacovigilance
      • Medical Affairs
      • Clinical Coordinator Office
      • Development Strategy / Regulatory Consulting
      • Drug Master File (DMF) Application
    • Clinical Solutions
      • Clinical Development in China
      • Multicenter Randomized Clinical Trial (MRCT)
      • Investigator Initiated Trial (IIT)
      • Development on Traditional Medicine and Food for Specified Health Uses (FOSHU)
      • Dispatch Business
      • Clinical Development Network in China
      • Clinical Trial in Southeast Asia
  • News
  • Recruitment
  • Group Network
  • Contact
  • JP

Regulatory Watch

  1. HOME
  2. News
  3. Regulatory Watch
2025年9月1日 / Last updated : 2025年9月12日 fmdkljp Regulatory Watch

Vietnam Regulatory Watch: Administrative Procedures, BE List Update, and Implementation Guidance – September 2025

Welcome to the September 2025 edition. This month we focus on three developments that affect regulatory operations, dossier planning, and compliance across Vietnam’s drug market. We hope this update provides valuable insights into the evolving regulatory landscape in Vietnam. Should you require further details or assistance in navigating these changes, please do not hesitate to […]

2025年8月12日 / Last updated : 2025年8月12日 fmdkljp Regulatory Watch

Indonesia Regulatory Watch: A Primer on Drug Registration in Indonesia – August 2025

Welcome to the August 2025 edition of our Indonesia Health Regulatory Update. This inaugural issue marks the beginning of a monthly series dedicated to exploring Indonesia’s pharmaceutical regulatory landscape. With a rapidly growing healthcare sector and one of the world’s largest populations, Indonesia presents a dynamic and growing pharmaceutical market. For companies seeking to register […]

2025年7月30日 / Last updated : 2025年7月30日 fmdkljp Regulatory Watch

Vietnam Regulatory Watch: Drug Regulatory Reforms and E-Commerce Expansion – August 2025

Welcome to our August 2025 Vietnam Health Regulatory Update. This month, we spotlight three key regulatory developments that are shaping the pharmaceutical landscape in Vietnam. These changes may offer both compliance challenges and strategic opportunities for Japanese pharmaceutical companies. We hope this update provides valuable insights into the evolving regulatory landscape in Vietnam. Should you […]

2025年7月16日 / Last updated : 2025年7月30日 fmdkljp Regulatory Watch

Vietnam Regulatory Watch: Drug & Population Policy Updates – July 2025

Welcome to our July 2025 Vietnam Health Regulatory Update. We are committed to keeping you informed about significant regulatory changes in Vietnam’s healthcare sector. Below are the key updates: 1. Abolition of Two-Child Policy and Introduction of Draft Population Law On June 3, 2025, Vietnam’s National Assembly approved amendments to the Population Ordinance, officially ending […]

  • All
  • News
  • Notice
  • Group
  • Regulatory Watch

Japan
3F, VORT HigashiNihonbashi 2,HigashiNihonbashi 3-4-1,Chuo Ku, Tokyo,〒103-0004,Japan
TEL: 03-6228-7360
FAX: 03-6701-2398

CHINA
11F Building A, Fenglin International Tower,
420 Fenglin Road,
Xuhui District, 200032, Shanghai

U.S.A
300 Welsh Road Building 5, Suite 201 Horsham, PA 19044 USA

Company Profile

  • Top Message・Corporate Philosophy
  • Company Profile・Our History
  • Leadership Team
  • Group Investors/Group Partners
  • Recruitment
  • Group Network
  • Contact
  • Privacy Policy

Service Sector

  • Regulatory Affairs
  • Clinical Operation
  • Data Management
  • Statistical Analysis/Programming
  • Medical Writting
  • Pharmacovigilance
  • Medical Affairs
  • Clinical Coordinator Office
  • Development Strategy / Regulatory Consulting
  • Drug Master File (DMF) Application

Development Needs

  • Clinical Development in China
  • Multicenter Randomized Clinical Trial (MRCT)
  • Investigator Initiated Trial (IIT)
  • Dispatch Business
  • Development on Traditional Medicine and Food for Specified Health Uses (FOSHU)
  • Clinical Development Network in China

Copyright © ClinChoice All Rights Reserved.

Powered by WordPress with Lightning Theme & VK All in One Expansion Unit

MENU
  • About ClinChoice
    • Top Message・Corporate Philosophy
    • Company Profile・Our History
    • Leadership Team
    • Group Investors/Group Partners
  • Service Offering
    • Service Sector
      • Regulatory Affairs
      • Clinical Operation
      • Data Management
      • Statistical Analysis/Programming
      • Medical Writting
      • Pharmacovigilance
      • Medical Affairs
      • Clinical Coordinator Office
      • Development Strategy / Regulatory Consulting
      • Drug Master File (DMF) Application
    • Clinical Solutions
      • Clinical Development in China
      • Multicenter Randomized Clinical Trial (MRCT)
      • Investigator Initiated Trial (IIT)
      • Development on Traditional Medicine and Food for Specified Health Uses (FOSHU)
      • Dispatch Business
      • Clinical Development Network in China
      • Clinical Trial in Southeast Asia
  • News
  • Recruitment
  • Group Network
  • Contact
  • JP
PAGE TOP